Novartis Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 2,125,538 | 0.104% |
| Private Companies | 89,202,482 | 4.37% |
| Institutions | 655,221,320 | 32.1% |
| General Public | 1,293,857,047 | 63.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 89,135,960 | US$8.8b | 0% | no data | |||
| 83,366,457 | US$8.2b | 1.55% | 0.14% | |||
| 61,129,038 | US$6.0b | 8.98% | 0.88% | |||
| 54,918,539 | US$5.4b | 1.43% | 0.47% | |||
| 50,178,623 | US$4.9b | 1.71% | 3.61% | |||
| 43,003,695 | US$4.2b | -1.55% | 0.72% | |||
| 17,436,123 | US$1.7b | -6.13% | 1.29% | |||
| 17,094,202 | US$1.7b | -0.12% | 1.35% | |||
| 14,157,452 | US$1.4b | 1.16% | 0.12% | |||
| 13,406,616 | US$1.3b | 3.08% | 0.91% | |||
| 12,169,577 | US$1.2b | 0.01% | 0.76% | |||
| 11,447,116 | US$1.1b | 0% | 9.22% | |||
| 8,413,865 | US$829.0m | 13% | 0.18% | |||
| 8,328,042 | US$820.5m | 0% | 0.1% | |||
| 8,036,452 | US$791.8m | 15.8% | 5.73% | |||
| 7,356,158 | US$724.8m | 3.86% | 0.15% | |||
| 7,307,615 | US$720.0m | -2.89% | 0.04% | |||
| 6,378,810 | US$628.5m | 1.16% | 0.27% | |||
| 6,359,661 | US$626.6m | -0.09% | 0.03% | |||
| 6,216,480 | US$612.5m | 3.93% | 1.51% | |||
| 6,114,340 | US$602.4m | 2.34% | 0.11% | |||
| 5,455,974 | US$537.6m | -0.92% | 0.05% | |||
| 5,359,261 | US$528.0m | -0.29% | 0.5% | |||
| 5,333,245 | US$525.5m | 0.19% | 0.27% | |||
| 4,623,737 | US$455.6m | 0% | 0.42% |